Berry Genomics Co.,Ltd

SZSE:000710 Voorraadrapport

Marktkapitalisatie: CN¥3.2b

Berry GenomicsLtd Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Berry GenomicsLtd's earnings have been declining at an average annual rate of -67%, while the Biotechs industry saw earnings growing at 5.9% annually. Revenues have been declining at an average rate of 7.9% per year.

Belangrijke informatie

-67.0%

Groei van de winst

-66.5%

Groei van de winst per aandeel

Biotechs Groei van de industrie11.3%
Inkomstengroei-7.9%
Rendement op eigen vermogen-14.6%
Nettomarge-25.4%
Laatste winstupdate30 Sep 2024

Recente prestatie-updates uit het verleden

Recent updates

Berry Genomics Co.,Ltd (SZSE:000710) Shares Fly 26% But Investors Aren't Buying For Growth

May 21
Berry Genomics Co.,Ltd (SZSE:000710) Shares Fly 26% But Investors Aren't Buying For Growth

Berry Genomics Co.,Ltd (SZSE:000710) Held Back By Insufficient Growth Even After Shares Climb 32%

Mar 08
Berry Genomics Co.,Ltd (SZSE:000710) Held Back By Insufficient Growth Even After Shares Climb 32%

Opbrengsten en kosten

Hoe Berry GenomicsLtd geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

SZSE:000710 Opbrengsten, kosten en inkomsten (CNY Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Sep 241,108-28251496
30 Jun 241,142-323548103
31 Mar 241,151-398561110
31 Dec 231,151-427567110
30 Sep 231,180-368575102
30 Jun 231,248-325554103
31 Mar 231,335-258566101
01 Jan 231,368-249561107
30 Sep 221,363-155526114
30 Jun 221,369-161530118
31 Mar 221,401-144527123
01 Jan 221,422-111510128
30 Sep 211,56588482128
30 Jun 211,553124461130
31 Mar 211,505170442127
31 Dec 201,540211435126
30 Sep 201,531228404127
30 Jun 201,585258398122
31 Mar 201,655285425133
31 Dec 191,618391414120
30 Sep 191,586342426118
30 Jun 191,549372422115
31 Mar 191,475370369108
31 Dec 181,44026838191
30 Sep 181,38731235163
30 Jun 181,29528834443
31 Mar 181,24426039434
31 Dec 171,17123339034
30 Sep 171,08921938526
30 Jun 171,05718840520
31 Mar 179541633770
31 Dec 169221513820
31 Dec 15446442170
31 Dec 14334461880
30 Sep 14276-7420
30 Jun 14271-8400
31 Mar 14248-6360
31 Dec 13262-6360

Kwaliteitswinsten: 000710 is currently unprofitable.

Groeiende winstmarge: 000710 is currently unprofitable.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: 000710 is unprofitable, and losses have increased over the past 5 years at a rate of 67% per year.

Versnelling van de groei: Unable to compare 000710's earnings growth over the past year to its 5-year average as it is currently unprofitable

Winst versus industrie: 000710 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (0.08%).


Rendement op eigen vermogen

Hoge ROE: 000710 has a negative Return on Equity (-14.58%), as it is currently unprofitable.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden